Teva Pharmaceutical Industries Ltd (TEVA.N)
22 Aug 2014
|Market Cap (Mil.):||$51,336.00|
|Shares Outstanding (Mil.):||952.04|
Aug 14 - Active Biotech : * Active biotech's partner teva initiates a laquinimod clinical trial in
* Now sees 2014 EPS $4.50-$4.80 with Copaxone competition
JERUSALEM, July 31 - Israeli industrialist Benny Landa said his campaign to improve corporate governance at Teva Pharmaceutical Industries was delivering results, despite losing a shareholder vote at the world's largest generic drugmaker.
July 31 - Teva Pharmaceutical Industries Ltd said:
TEL AVIV, July 31 - Teva Pharmaceutical Industries reported on Thursday higher quarterly earnings that beat analysts' estimates by one cent due in part to the launch of several generic products in the United States.
July 30 - Israeli drugmaker Teva Pharmaceuticals Industries said on Wednesday it turned back efforts by Israeli industrialist Benny Landa to shake up the company's board of directors, with shareholders approving all of the company's proposals and board nominations.
TEL AVIV, July 14 - Teva Pharmaceutical Industries board is to appoint vice-chairman Amir Elstein as its new chairman, activist shareholder Benny Landa said on Monday.
* Six companies get combined penalty of 428 million euros
BRUSSELS, July 9 - European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others 427.7 million euros ($583.40 million) on Wednesday for blocking cheaper generic medicine.
TEL AVIV, July 3 - Teva Pharmaceutical Industries has filed a so-called citizen petition with the U.S. Food and Drug Administration (FDA), aiming to delay cheap generic competition to Copaxone, its top-selling treatment for multiple sclerosis (MS).